Inari Medical, Inc. (NASDAQ:NARI) Q3 2022 Earnings Conference Call November 2, 2022 4:30 PM ET

Company Participants

Caroline Corner – Investor Relations

Bill Hoffman – President and Chief Executive Officer

Drew Hykes – Chief Operating Officer

Mitch Hill – Chief Financial Officer

Tom Tu – Chief Medical Officer

Conference Call Participants

Travis Steed – Bank of America

Cecilia Furlong – Morgan Stanley

Larry Biegelsen – Wells Fargo

Marie Thibault – BTIG

Bill Plovanic – Canaccord Genuity

Adam Maeder – Piper

Richard Newitter – Truist Securities

Dev Weerasuriya – Berenberg Capital Markets

Operator

Good day and welcome to the Inari Medical, Inc. Third Quarter 2022 Earnings Conference Call. All participants will be in listen-only mode. [Operator instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note today’s event is being recorded.

I would now like to turn the conference over to Caroline Corner, Investor Relations. Please go ahead.

Caroline Corner

Thank you, operator. Welcome to Inari’s third quarter 2022 earnings call. Joining me on today’s call are Bill Hoffman, President and Chief Executive Officer; Drew Hykes, Chief Operating Officer; and Mitch Hill, Chief Financial Officer. This call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical facts should be considered forward-looking statements, including statements regarding the markets in which Inari operates, trends and expectations for Inari’s products and technology, trends in demand for Inari’s products, Inari’s expected financial performance, expenses and position in the market; and the impact of COVID-19 on Inari’s operations and Inari’s customers’ operations.

These statements are neither promises nor guarantees and involve known and unknown risks and uncertainties that could cause actual results, performance or achievements to differ materially from any results, performance or achievements expressed or implied by the forward-looking statements. Please review Inari’s most recent filings with the SEC, particularly the risk factors described in Inari’s annual report on Form 10-K for the year ended December 31, 2021, for additional information. Any forward-looking statements provided during this call, including projections for future performance, are based on management’s expectations as of today.

Inari undertakes no obligation to update these statements, except as required by applicable law. Inari’s press release for the third quarter 2022 results is available on Inari’s website, www.inarimedical.com, under the Investors section and includes additional details about Inari’s financial results. Inari’s website also has the latest SEC filings, which you are encouraged to review. A recording of today’s call will be available on Inari’s website by 5:00 p.m. Pacific Time today.